chr13-71771373-C-T
Variant names:
Variant summary
Our verdict is Benign. The variant received -12 ACMG points: 0P and 12B. BP4_StrongBA1
The NM_080759.6(DACH1):c.849-89463G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.504 in 150,446 control chromosomes in the GnomAD database, including 20,467 homozygotes. In-silico tool predicts a benign outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar.
Frequency
Genomes: 𝑓 0.50 ( 20467 hom., cov: 30)
Consequence
DACH1
NM_080759.6 intron
NM_080759.6 intron
Scores
2
Clinical Significance
Not reported in ClinVar
Conservation
PhyloP100: 0.182
Publications
9 publications found
Genes affected
DACH1 (HGNC:2663): (dachshund family transcription factor 1) This gene encodes a chromatin-associated protein that associates with other DNA-binding transcription factors to regulate gene expression and cell fate determination during development. The protein contains a Ski domain that is highly conserved from Drosophila to human. Expression of this gene is lost in some forms of metastatic cancer, and is correlated with poor prognosis. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Sep 2009]
Genome browser will be placed here
ACMG classification
Classification was made for transcript
Our verdict: Benign. The variant received -12 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.9).
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.847 is higher than 0.05.
Transcripts
RefSeq
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
DACH1 | ENST00000613252.5 | c.849-89463G>A | intron_variant | Intron 1 of 10 | 1 | NM_080759.6 | ENSP00000482245.1 | |||
DACH1 | ENST00000619232.2 | c.849-89463G>A | intron_variant | Intron 1 of 11 | 5 | ENSP00000482797.1 | ||||
DACH1 | ENST00000706274.1 | c.390-89463G>A | intron_variant | Intron 1 of 9 | ENSP00000516320.1 |
Frequencies
GnomAD3 genomes AF: 0.504 AC: 75738AN: 150328Hom.: 20417 Cov.: 30 show subpopulations
GnomAD3 genomes
AF:
AC:
75738
AN:
150328
Hom.:
Cov.:
30
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome AF: 0.504 AC: 75851AN: 150446Hom.: 20467 Cov.: 30 AF XY: 0.511 AC XY: 37575AN XY: 73532 show subpopulations
GnomAD4 genome
AF:
AC:
75851
AN:
150446
Hom.:
Cov.:
30
AF XY:
AC XY:
37575
AN XY:
73532
show subpopulations
African (AFR)
AF:
AC:
26646
AN:
41232
American (AMR)
AF:
AC:
8514
AN:
15108
Ashkenazi Jewish (ASJ)
AF:
AC:
1356
AN:
3456
East Asian (EAS)
AF:
AC:
4479
AN:
5158
South Asian (SAS)
AF:
AC:
2781
AN:
4810
European-Finnish (FIN)
AF:
AC:
4269
AN:
10294
Middle Eastern (MID)
AF:
AC:
129
AN:
292
European-Non Finnish (NFE)
AF:
AC:
26381
AN:
67090
Other (OTH)
AF:
AC:
1013
AN:
2094
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.506
Heterozygous variant carriers
0
1750
3500
5251
7001
8751
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Age Distribution
Genome Het
Genome Hom
Variant carriers
0
658
1316
1974
2632
3290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
2460
AN:
3460
ClinVar
Not reported inComputational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
DANN
Benign
PhyloP100
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at
Publications
You must be logged in to view publications. This limit was set because tens of millions (!) of queries from AI bots are generated daily.